Usana Gets Bid From CEO-Led Group

An investors' group controlled by the chief executive of Usana Health Sciences Inc. is offering to take it private in a deal that values the vitamin company at about $426 million.

Myron Wentz, Usana's majority shareholder and CEO, said he had assembled a group holding 68% of the company's shares and would offer $26 a share, or about $136 million, for the shares the group didn't already own. ...